|
HOOK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.653000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.594830E-01 |
| Normal-vs-Stage2 |
9.082400E-01 |
| Normal-vs-Stage3 |
2.732200E-01 |
| Normal-vs-Stage4 |
4.258800E-01 |
| Stage1-vs-Stage2 |
3.750400E-01 |
| Stage1-vs-Stage3 |
9.996600E-01 |
| Stage1-vs-Stage4 |
8.032800E-01 |
| Stage2-vs-Stage3 |
4.482400E-01 |
| Stage2-vs-Stage4 |
4.708600E-01 |
| Stage3-vs-Stage4 |
7.859000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.042200E-01 |
| Normal-vs-AfricanAmerican |
5.142800E-01 |
| Normal-vs-Asian |
2.560300E-03 |
| Caucasian-vs-AfricanAmerican |
7.453200E-01 |
| Caucasian-vs-Asian |
1.356210E-01 |
| AfricanAmerican-vs-Asian |
1.204980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.391900E-02 |
| Normal-vs-Female |
3.640400E-01 |
| Male-vs-Female |
1.200080E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.129000E-01 |
| Normal-vs-Extreme_Weight |
8.076400E-02 |
| Normal-vs-Obese |
8.690800E-01 |
| Normal-vs-Extreme_Obese |
2.778400E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.364800E-01 |
| Normal_Weight-vs-Obese |
4.517800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.445400E-01 |
| Extreme_Weight-vs-Obese |
1.712750E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.206800E-01 |
| Obese-vs-Extreme_Obese |
1.877790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.129600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.229200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.504100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.270640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.629400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.148000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.321000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.019990E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.682000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.780600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.555600E-01 |
| Normal-VS-Type2 PRCC |
4.595200E-04 |
| Normal-VS-KIRP CIMP |
4.784200E-01 |
| Normal-VS-Unclassified PRCC |
9.860000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.227300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.027200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.808200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.016300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.812000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.599800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.804800E-03 |
| Normal-vs-N1 |
9.543000E-01 |
| Normal-vs-N2 |
6.953000E-01 |
| N0-vs-N1 |
7.114300E-02 |
| N0-vs-N2 |
3.547400E-01 |
| N1-vs-N2 |
8.169000E-01 |
|
|
